MTX-HOPE is a low-dose salvage chemotherapy for aged patients with relapsed or refractory non-Hodgkin lymphoma

As the aging society advances, the number of non-Hodgkin lymphoma (NHL) patients is increasing. Aged relapsed or refractory (r/r) NHL patients have limited treatment options. Therefore, a safe and effective regimen is urgently needed for these patients. Thus, we originally developed the MTX-HOPE (me...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Manabu, Tsunoda, Saburo, Koyama, Daisuke, Ikeda, Shohei, Sukegawa, Masumi, Hojo, Hiroshi, Ohta, Masatsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JSLRT 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053567/
https://www.ncbi.nlm.nih.gov/pubmed/33551437
http://dx.doi.org/10.3960/jslrt.20051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053567/
https://www.ncbi.nlm.nih.gov/pubmed/33551437
http://dx.doi.org/10.3960/jslrt.20051

Ejemplares similares